George Magrath
Chief Executive Officer, Director · Opus Genetics, Inc.
- 2024
- Sep 11, 2026
- 10
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies George Magrath files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Foundation Fighting Blindness Retinal Degeneration Fund - $10.15M in IRD purchases and sales in the last 12 months
- Cam Gallagher - $324K in IRD purchases and sales in the last 12 months
- Robert E. Gagnon - $191K in IRD purchases and sales in the last 12 months
- Benjamin R. Yerxa - $61K in IRD purchases and sales in the last 12 months
- Ashwath Jayagopal - $58K in IRD purchases and sales in the last 12 months
- Joseph K. Schachle - $58K in IRD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is George Magrath?
George Magrath is a corporate insider, tracked as Chief Executive Officer, Director of Opus Genetics, Inc. (IRD). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has George Magrath submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has George Magrath been buying or selling stock?
Recorded transactions: 3 open-market purchases ($199K) and 3 open-market sales ($205K) across all tracked filings.
